WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) today announced that the Company will present new data from across its oncology portfolio at the 2024 American Society of Hematology (ASH) ...
UK policy aims to improve cancer outcomes by promoting early diagnosis, which for many haematological malignancies is particularly challenging as the pathways leading to diagnosis can be difficult and ...
Fludarabine, Melphalan, and Alemtuzumab Conditioning in Adults With Standard-Risk Advanced Acute Myeloid Leukemia and Myelodysplastic Syndrome From a total of 2,715 patients with biopsy-proven HL ...
B-cell lymphoma is a cancer that forms in white blood cells called lymphocytes. These cells are made by your bone marrow and play an important role in your body's ability to fight infections. These ...
T-cell lymphoma is a relatively uncommon cancer affecting lymphocytes, a type of white blood cell crucial for immune function. The symptoms of T-cell lymphoma may vary widely depending on the specific ...
AYA lymphoma patients often experience delayed diagnosis due to transitional life stages and lack of primary care or insurance. Lymphoma types and presentations in AYAs differ from those in children ...
SOUTH SAN FRANCISCO, Calif., June 09, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results